METALS, MINING AND ENERGY
Tungsten Mining (ASX: TGN) announced a 140-hole, 40,000m RC drilling program at its Mt Mulgine project commencing early May 2026, designed to test depth extensions beneath the 2020 Mineral Resource Estimate. With potential to upgrade up to 100 Mt into the Indicated category and add to the existing 270 Kt of contained WO3, the program could position Mt Mulgine as one of the largest tungsten resources globally amid record high tungsten prices. Covered by Proactive.
Syrah Resources (ASX: SYR) confirmed that the cure date relating to Tesla’s alleged default notice under the Vidalia AAM offtake agreement has been extended to 1 June 2026. The notice relates to the supply of conforming natural graphite active anode material from Syrah’s 11.25ktpa Vidalia facility in Louisiana. While Syrah does not accept it is in default, the company and Tesla are collaborating to resolve the matter and complete final qualification of Vidalia AAM, with the extension subject to consent from the U.S. Department of Energy.
Native Mineral Resources (ASX: NMR) secured exclusive mining rights over the Podosky Gold Project, northern Queensland, which was previously part of the Ravenswood JV between NMR and Haoma Mining NL. Under the term sheet, NMR will have exclusive rights to carry out mining activities to extract gold and silver from Podosky for a 12-month period. NMR will haul material from Podosky to process at its Blackjack Operations, 75km west of Podosky.
Everest Metals (ASX: EMC) reported strong results from its recent grade control RC drilling at the Mt Dimer Tapian Gold Project. A 2,160m infill program has boosted geological and financial confidence in the Mt Dimer Taipan gold pit, returning several significant gold intersections including: 8m @ 10.1 g/t Au (35–43m) inc., 2m @ 29.8 g/t Au from 36m. Covered by Small Caps, Stockhead & The Australian.
Premier1 (ASX: PLC) completed a 16-hole (2,776m) RC drilling campaign at its Yalgoo gold project in Western Australia, targeting high-priority zones across Mt Kersey, Central Block, Carlisle and Crescent South as it builds its presence in the region’s prospective greenstone belt. Assay results expected in 4-6 weeks. Covered by BullsNBears.
IRIS Metals (ASX: IR1) acquired historical Union Carbide Corporation exploration data for its high-grade Finley Basin Tungsten Project. The dataset includes drill logs, geological interpretations, regional mapping and surface sampling data.The Company is targeting Q3 2026 for drill mobilisation, strengthening its U.S. tungsten exposure. Covered by The Australian, Mining.com.au and Stockhead.
Galilee Energy (ASX: GLL) finalised the well location and drilling configuration for its Zydeco-1 appraisal well at its 100%-owned Zydeco Gas Project in Louisiana, with spud on track for Q2 2026. Targeting the Upper and Lower Tweedel reservoirs, the well offers potential for up to 8 Bcf of gas and 0.5 MMbbl of condensate, with additional upside identified in the Homeseeker B sand interval where previously unmodelled oil entrapment has been recognised.
Auric Mining (ASX: AWJ) provided a final report on the Munda Gold Mine Starter Pit, following completion of the Gold in Circuit (GIC) calculation after the fourth and final gold outturn from ore processed at Black Cat Syndicate Ltd’s (ASX: BC8) Lakewood Mill. A total of 8,886 ounces were produced from the Munda Starter Pit, exceeding budget by 46%. Campaign Two recorded a Gold in Circuit (GIC) of 411 ounces, with 126,000 tonnes processed at an average head grade of 2.46g/t, including 3.18g/t for Campaign Two. The operation achieved an average total recovery rate of 89.5%, with Campaign Two delivering 88.67%. Covered by BullsNBears.
Raptor Metals (ASX: RAP) completed a 2126m diamond drill program at the Chester Project, New Brunswick, Canada, comprising 16 HQ holes and 3 PQ holes. The final PQ metallurgical holes are currently being processed, while the remaining HQ core samples are being prepared for assay submission and all PQ core samples are being readied for metallurgical testing. Assay results are expected within four to eight weeks.
Lakes Blue Energy (ASX: LKO) provided an exploration update highlighting the completion of its expanded technical team, strengthening in-house capability across reservoir engineering and geophysics to support increased activity across its portfolio. The Company has commenced production testing at the Wombat-5 well, with early indications of enhanced gas flow, while advancing plans for a Gippsland Basin seismic survey and progressing regulatory work at the Portland Energy Project, targeting potential drilling of up to two wells in 2026.
Perpetual Resources (ASX: PEC) reported results from the recently completed soil geochemistry programs at its Igrejinha Project in Minas Gerais, Brazil. The program identified a new prospect, Pico Grande, located ~750m northwest of Morro Grande.
RENEWABLE ENERGY
BPH Global (ASX: BP8) provided an update on the advancement of its seaweed-based research and development (R&D) program and the associated opportunity to produce renewable biofuels from seaweed biomass that may partially replace fossil fuels across energy, fuel and transport markets.
NH3 Clean Energy (ASX: NH3) executed a binding Water Supply Agreement with the Water Corporation of WA for Phase 1 of its WAH2 clean ammonia project. The agreement is the first of the company's preliminary commercial arrangements to be converted into a definitive binding agreement ahead of a Final Investment Decision, with evaluation of FEED engineering proposals and selection of a FEED partner expected to be announced in the coming weeks.
Hazer Group Ltd (ASX: HZR) signed a non-binding MOU and graphite offtake LOI with Green Steel of WA for the supply of up to 85,000 tonnes of graphite over a 10-year term at its proposed Collie Steel Mill, commencing 2030. Pricing will be linked to the landed anthracite benchmark price. The agreement marks Hazer's first commercial graphite offtake with a steelmaking customer, validating the company's graphite monetisation strategy and the Hazer Process's applicability to low-emissions steel manufacturing.
Frontier Energy (ASX: FHE) announced a change in directors’ interest for Executive Chairman Jamie Cullen and Non-Executive Director Grant Davey. Mr Cullen and Mr Davey combined to acquire a total of 3 million shares in Frontier through on-market purchases, as follows: Executive Chairman Mr Cullen, who became a director on 2 March 2026, acquired 1,000,000 Frontier shares on market; and Non-Executive Director and major shareholder, Mr Davey acquired 2,000,000 Frontier shares and now holds 71,104,214 Frontier shares. View FHE’s latest investor presentation here.
INDUSTRIALS
Bio Gene Technology (ASX: BGT) signed a non-binding term sheet with Sumitomo Corporation and Nakashima Trading Co. to develop and market insecticide products containing its 100 percent natural Qcide® for Japan’s household nuisance insect market, targeting a launch in late 2026. Under the proposed arrangement, Bio Gene will supply Qcide oil produced from its Queensland eucalyptus plantations, while Sumitomo will manage ordering, trade financing and logistics and Nakashima will handle formulation, packaging, promotion and retail distribution. The partnership targets Japan’s home insecticide market, estimated at about US$1 billion annually, with definitive agreements expected by April or May 2026.
BIOTECH
Syntara (ASX: SNT) received a A$1.7 million milestone payment from Parkinson’s UK following dosing of the final patient in its Phase 2 trial of SNT-4728, which is being evaluated for neuroinflammation associated with early stage Parkinson’s disease. The study is focused on patients with isolated REM sleep behaviour disorder, a strong early indicator of Parkinson’s and related disorders, with top line safety and efficacy results expected in Q2 CY2026. Syntara remains eligible for a further A$0.45 million milestone payment upon completion of the project.
Imricor Medical Systems (ASX: IMR) filed a Form 10 Registration Statement with the U.S. Securities and Exchange Commission, following continued growth in its shareholder base beyond regulatory thresholds. The filing is expected to become effective by mid-May 2026, at which point Imricor will transition to a U.S. public reporting company, enhancing transparency and governance while maintaining its primary ASX listing.
EMVision Medical Devices (ASX: EMV) received a $3.8 million R&D tax refund for FY2025 and secured AusIndustry approval for its Advance Overseas Finding, covering eligible overseas costs tied to the emu™ pivotal trial and market access activities. The approval allows EMVision to access the Australian Government’s 43.5% R&D tax rebate on qualifying overseas expenditure across FY2025–FY2027, strengthening the Company’s funding position as it advances the emu™ trial and related initiatives.
Nexalis Therapeutics (NX1) commenced dosing in its first in human Phase 1 trial of IRX-616a, with the first participant treated in a study evaluating safety, tolerability and pharmacokinetics for the treatment of panic disorder. The randomised, double blind, placebo controlled trial will enrol up to 24 healthy volunteers across three dose cohorts, with dose escalation subject to review by an independent Safety Review Committee, which is scheduled to meet in early April 2026. The trial remains on track to complete dosing by the end of June 2026, supporting progression to a planned Phase 2 study.
Arovella Therapeutics (ASX: ALA) announced the Therapeutic Goods Administration (TGA) has confirmed that the Company’s planned Australian Phase 1 clinical trial of ALA-101, its allogeneic CD19-targeting CAR-iNKT cell therapy, can proceed under the Clinical Trial Notification Scheme. The TGA’s confirmation follows the recent clearance of Arovella’s Investigational New Drug application by the U.S. FDA, supported by a comprehensive preclinical and manufacturing data package, to initiate a first-in-human clinical trial for ALA-101 in both Australia and the United States.
ECS Botanics (ASX: ECS) revealed in an NWR Communications-hosted investor webinar that it plans to relaunch Terphogz medicinal cannabis products into the Australia and international markets over the next six months - covered by Cannabiz.
BPH Global (ASX: BP8) provided an interim update on the progress of Project Giddy-Up, its proprietary seaweed-based men’s health supplement program. The Company confirms that it has now finalised the formulation, including the specific ingredients and the proportions of each component. This milestone represents the completion of formulation development and positions the project to advance into its planned validation phase.
CORPORATE NEWS
Power Minerals (ASX: PNN) appointed REE specialist Alistair Stephens as CEO, bringing +35 years of experience across critical minerals and resources development. Stephens previously served as MD and CEO of Arafura Rare Earths and Lindian Resources, where he helped advance major rare earths projects to development and construction. He will lead Power’s strategy to progress its South American critical minerals portfolio, including advancing the Santa Anna Rare Earth Project in Brazil toward a maiden Mineral Resource Estimate, completing due diligence on the Morro do Ferro project, and progressing the Salta Lithium Projects in Argentina. Covered by Stockhead.
Sparc Technologies (ASX: SPN) announced a dual listing on the Frankfurt Stock Exchange (ticker: NLR), retaining its primary ASX listing. The secondary listing supports the company's growing engagement with European corporates across its graphene-based additives and Sparc Hydrogen technologies, while providing access to EU retail and institutional investors.
Chariot Resources Ltd (ASX: CC9) received firm commitments for a placement raising A$2.15 million before costs, through the issuance of 21.5 million fully paid ordinary Chariot shares at a price of A$0.10 per share. The placement was strongly supported by institutional, sophisticated and professional investors, including existing shareholders, long-term lithium investors and associates of GBA Capital Pty Ltd. GBA Capital served as Lead Manager to the placement.
Middle Island Resources (ASX: MDI) appointed Sanela Karic as Non-Executive Director. Sanela is an experienced legal, governance and corporate affairs professional with more than 25 years of international experience spanning corporate law, mergers and acquisitions, human resources and stakeholder engagement across Europe and the Balkans.She brings listed company board expertise, including as a Non-Executive Director of Adriatic Metals plc, and currently serves as President of the Foreign Investors Council in Bosnia and Herzegovina.
Energy World Corporation’s (ASX: EWC) appointment of Alan Jowell as Executive Chairman was covered by Upstream.
CurveBeam AI (ASX: CVB) has appointed Patrick Fisher as an Independent Non-Executive Director of the Company, effective immediately. Mr Fisher is US-based and a highly experienced global orthopaedic industry executive with more than two decades of leadership experience across global medical device organisations. He currently serves as President of Global Biologics and Limb Reconstruction at Orthofix and has previously held senior leadership roles at Stryker and Wright Medical Group, where he was involved across knee, hip, and foot & ankle segments.
InteliCare Holdings (ASX: ICR) appointed Angus Cameron as Chief Executive Officer, effective immediately. Mr Cameron is a highly accomplished international aged and health care executive with more than 30 years’ experience leading large-scale aged and health care businesses, large scale consultancy and advisory as well as business transformations across Australia, Asia Pacific and the United States.
%20(14).png?upscale=true&width=1120&upscale=true&name=Copy%20of%20Copy%20of%202%20Weekly%20Wrap%20section%20dividers%20(1200%20%C3%97%20180px)%20(14).png)
